The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function.
D000925:Anticoagulants / Q000627:therapeutic use; D001706:Biopsy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004338:Drug Combinations; D004906:Erythrocyte Count; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006417:Hematuria / Q000652:urine; D006801:Humans; D006974:Hypertension, Malignant / Q000188:drug therapy*; D007668:Kidney / Q000473:pathology; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011379:Prognosis; D011507:Proteinuria / Q000188:drug therapy; D014556:Urine / Q000166:cytology
D000925:Anticoagulants; D004338:Drug Combinations; D004176:Dipyridamole; D003520:Cyclophosphamide